Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Finance and funding news

Show

From To
IDWeek 2014: Behavioral and Financial Incentives May Improve HIV Treatment Outcomes

While making medications free can remove barriers to access for individuals who cannot pay for treatment, data suggest that for most people accessing care in industrialized countries, "making medications available for free or low cost will not solve problems with medication non-adherence," according to a presentation by Kevin Volpp from the University of Pennsylvania last week at IDWeek 2014 in Philadelphia.

Published
16 October 2014
From
HIVandHepatitis.com
Unique 'pay if you clear' proposal for new hepatitis drug

The NHS in Scotland could be reimbursed for the cost of a new hepatitis drug if sufferers fail to clear the virus. The novel proposal was revealed after the drug Olysio was cleared for use by the Scottish Medicines Consortium (SMC).

Published
15 October 2014
From
BBC
Fair Pricing Coalition Urges a Uniform Price for Curative Hepatitis C Treatment

The $63,000 wholesale acquisition cost (WAC) for eight weeks of Harvoni™ (sofosbuvir and ledipasvir) should be extended to 12 and 24-week curative treatment durations.

Published
15 October 2014
From
Fair Pricing Coalition
As Hepatitis Pill Harvoni Joins Sovaldi, States Erect Medicaid Hurdles

As Gilead Sciences launches its next generation Hepatitis C pill, Harvoni, Medicaid programs are bracing for another extraordinary wave of costs, with 70 percent of states implementing coverage restrictions.

Published
10 October 2014
From
Forbes
Sovaldi ‘unaffordable’ says NHS documents

Senior health officials may have to bar Gilead’s new hepatitis C pill Sovaldi from being funded on the NHS after new data shows it would cost the health service £1 billion a year to fund.

Published
08 October 2014
From
Pharmafile
How Some State Medicaid Programs Limit Drugs to Only the Sickest Patients

Because of its high cost, some state Medicaid programs and prison systems are refusing to provide Sovaldi to any but the sickest patients. Most recently, Oregon last month threatened to limit access to the drug unless it can get Sovaldi at a deeply discounted price. What can states do to hold down drug costs? Drug pricing is a complicated and opaque process. Here are some of the basics.

Published
07 October 2014
From
Governing.com
Treatment Action Campaign faces closure

After almost two decades spent fighting for HIV treatment and access to medicines, the Treatment Action Campaign (TAC) may close its doors due to a severe funding shortage.

Published
01 October 2014
From
Health-e
France uses tax to put pressure on hepatitis C drug prices

France will tax drugmakers whose costly hepatitis C drugs threaten to throw off course its healthcare budget, the government has said, heaping pressure on pharmaceutical companies like Gilead Sciences to cut their prices.

Published
01 October 2014
From
Reuters
PrEP will need high adherence, high effectiveness and high coverage in specific populations to be affordable in the US, New York study finds

A study based on New York City that modelled pre-exposure prophylaxis (PrEP) uptake there has found that in order to be affordable, PrEP would need to be

Published
01 October 2014
By
Gus Cairns
Hard choices in Russia as the final HIV grant proposal is submitted

The concept note delivered on 8 September for Russia's last HIV grant from the Global Fund was a perfect illustration of the conundrum facing a growing number of Eastern European/Central Asian countries: how to do more with less to fight a widening HIV epidemic. As more countries from the region 'graduate' from Global Fund eligibility due to their income classification, the funds that they could once count on to support prevention, harm reduction and other programs targeting vulnerable populations are disappearing. And there is little evidence that most national budgets are prepared or able to fill the vacuum.

Published
25 September 2014
From
Aidspan
← First12345...69Next →

Filter by country